NCT03954093

Brief Summary

Chronic pain patients with implanted dorsal root ganglion stimulators will be randomized to receive transcranial direct current stimulation (tDCS) to the motor cortex, magneto-encephalographically (MEG) localized stimulation or sham stimulation to identify therapeutic efficacy of paired central and peripheral neuromodulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable chronic-pain

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

May 10, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 17, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2019

Completed
Last Updated

April 6, 2020

Status Verified

May 1, 2019

Enrollment Period

8 months

First QC Date

May 10, 2019

Last Update Submit

April 2, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in pain scores: 21-point pain scale rating

    21-point pain scale rating

    Immediately after 30 minutes of transcranial direct current stimulation

Secondary Outcomes (2)

  • Changes in EEG recordings

    Immediately after 30 minutes of transcranial direct current stimulation

  • Changes in Facial Expression Recognition Performance

    Immediately after 30 minutes of transcranial direct current stimulation

Study Arms (3)

Sham stimulation

SHAM COMPARATOR
Device: Transcranial direct current stimulation

Motor cortex stimulation

ACTIVE COMPARATOR
Device: Transcranial direct current stimulation

MEG-localized stimulation

EXPERIMENTAL
Device: Transcranial direct current stimulation

Interventions

tDCS produces hyper/hypopolarizing potentials in the cortex underlying the scalp electrodes and can increase/decrease the excitability of targeted brain regions.

Also known as: tDCS
MEG-localized stimulationMotor cortex stimulationSham stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who are willing and able to give consent to the study.
  • Male or Female, aged 18 years or above with diagnoses of chronic pain.
  • Treatment includes Spinal Cord Stimulation, Dorsal Root Ganglion stimulation, or peripheral analgesic stimulation.

You may not qualify if:

  • Patients who do not wish to be in the study.
  • Patients with metallic intracranial implants.
  • Patients with extreme language barrier that cannot understand the purpose of the study despite the use of an interpreter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

John Radcliffe Hospital

Oxford, Oxfordshire, OX3 9DU, United Kingdom

Location

MeSH Terms

Conditions

Chronic Pain

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Alex Green, FRCS

    University of Oxford

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2019

First Posted

May 17, 2019

Study Start

May 1, 2019

Primary Completion

December 20, 2019

Study Completion

December 20, 2019

Last Updated

April 6, 2020

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Patient diagnoses and demographics will be shared but identities kept anonymous

Locations